Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer-Reference-Cited by-同舟云学术

Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer

Published:2018 Issue:7 Volume:8 Page:3512-3521
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Gautam Swetlana¹²³⁴⁵,Singh Priyanka¹²³⁴⁵,Singh Manjari¹²³⁴⁵,Roy Subhadeep¹²³⁴⁵,Rawat Jitendra K.¹²³⁴⁵,Yadav Rajnish K.¹²³⁴⁵,Devi Uma¹⁶⁷⁸⁹,Gupta Pushpraj S.¹⁶⁷⁸⁹,Saraf Shubhini A.¹²³⁴⁵,Kaithwas Gaurav¹²³⁴⁵^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences

2. School of Biosciences and Biotechnology

3. Babasaheb Bhimrao Ambedkar University (A Central University)

4. Lucknow-226 025

5. India

6. Faculty of Health Medical Sciences Indigenous and Alternative Medicine

7. SHIATS-Deemed to be University

8. Formerly Allahabad Agricultural Institute

9. Allahabad

Abstract

The present study was proposed to investigate the effect of rifaximin (RFX) on methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats.

Funder

University Grants Commission

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C7RA09689E

Reference51 articles.

1. 2004 Drug Approval Highlights FDA Update

2. Rifaximin: An Antibiotic with Important Biologic Effects

3. Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway